• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铅暴露与 Tau 过度磷酸化:一项体外研究。

Lead exposure and tau hyperphosphorylation: An in vitro study.

机构信息

George and Anne Ryan Institute for Neuroscience, University of Rhode Island, Kingston, RI, USA.

Interdisciplinary Neuroscience Program, University of Rhode Island, Kingston, RI, USA.

出版信息

Neurotoxicology. 2017 Sep;62:218-223. doi: 10.1016/j.neuro.2017.07.029. Epub 2017 Jul 29.

DOI:10.1016/j.neuro.2017.07.029
PMID:28765091
Abstract

The presence of fibrillary lesions, which are mainly composed of the microtubule associated protein tau (MAPT) in neurons, has gained immense recognition due to their presence in numerous neurodegenerative diseases, including Alzheimer's disease (AD). Dysregulation of tau is related with its altered site-specific phosphorylation which is followed by tau polymerization, neuronal dysfunction and death. Previous reports by us suggest that molecular alterations favor abundant tau phosphorylation and immunoreactivity in the frontal cortex of aged primates and rodents with past exposure to lead (Pb). Here we report the involvement of Pb-induced alterations in tau and hyperphosphorylation of tau in differentiated Human Neuroblastoma SH-SY5Y cells exposed to a series of Pb concentrations (5-100μM) for 48h. These cells were analyzed for the protein expression of total tau, site-specific tau hyperphosphorylation, cyclin dependent kinase 5 (CDK5) and p35/p25 at selected time points (24-144h), after Pb exposure had ceased. Western blot analysis revealed aberrant tau levels as well as site-specific tau hyperphosphorylation accompanied by elevated CDK5 levels and altered protein ratio of p35/p25 particularly at 72 and 144h. These changes provide additional evidence that neurodegenerative events are subject to environmental influences.

摘要

由于其在包括阿尔茨海默病(AD)在内的许多神经退行性疾病中的存在,纤维状病变(主要由神经元中的微管相关蛋白 tau(MAPT)组成)得到了广泛的认可。tau 的失调与其特定部位磷酸化的改变有关,随后是 tau 聚合、神经元功能障碍和死亡。我们之前的报告表明,分子改变有利于过去接触过铅(Pb)的老年灵长类动物和啮齿动物的额皮质中丰富的 tau 磷酸化和免疫反应性。在这里,我们报告了在分化的人神经母细胞瘤 SH-SY5Y 细胞中,Pb 诱导的 tau 改变和 tau 的过度磷酸化的参与,这些细胞在停止 Pb 暴露后,暴露于一系列 Pb 浓度(5-100μM)48h。在 Pb 暴露后的选定时间点(24-144h),对这些细胞进行总 tau、tau 特定部位过度磷酸化、细胞周期蛋白依赖性激酶 5(CDK5)和 p35/p25 的蛋白表达进行了分析。Western blot 分析显示异常的 tau 水平以及伴随的 tau 特定部位过度磷酸化,同时 CDK5 水平升高和 p35/p25 的蛋白比例改变,特别是在 72 和 144h。这些变化提供了更多证据表明神经退行性事件受到环境影响。

相似文献

1
Lead exposure and tau hyperphosphorylation: An in vitro study.铅暴露与 Tau 过度磷酸化:一项体外研究。
Neurotoxicology. 2017 Sep;62:218-223. doi: 10.1016/j.neuro.2017.07.029. Epub 2017 Jul 29.
2
Infantile postnatal exposure to lead (Pb) enhances tau expression in the cerebral cortex of aged mice: relevance to AD.婴儿期出生后接触铅(Pb)会增强老年小鼠大脑皮层中tau蛋白的表达:与阿尔茨海默病的相关性。
Neurotoxicology. 2014 Sep;44:114-20. doi: 10.1016/j.neuro.2014.06.008. Epub 2014 Jun 20.
3
Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.围产期铅暴露以依赖糖原合酶激酶-3β(GSK-3β)和细胞周期蛋白依赖性激酶5(CDK5)的方式促进大鼠大脑中的 Tau 蛋白磷酸化:与神经疾病的相关性。
Toxicology. 2016 Mar 10;347-349:17-28. doi: 10.1016/j.tox.2016.03.002. Epub 2016 Mar 21.
4
Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb).婴幼儿时期暴露于铅(Pb)后,灵长类动物大脑在数十年后出现增强的tau 病理学和类似 AD 的病理学。
Neurotoxicology. 2013 Dec;39:95-101. doi: 10.1016/j.neuro.2013.07.010. Epub 2013 Aug 21.
5
Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells.谷氨酸处理和p25转染可增加SH-SY5Y细胞中Cdk5介导的tau蛋白磷酸化。
Biochem Biophys Res Commun. 2006 Jun 23;345(1):324-31. doi: 10.1016/j.bbrc.2006.04.032. Epub 2006 May 6.
6
Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.细胞周期蛋白依赖性激酶5激活剂p35裂解为p25不会诱导tau蛋白过度磷酸化。
Biochem Biophys Res Commun. 2002 Nov 15;298(5):693-8. doi: 10.1016/s0006-291x(02)02543-3.
7
A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.一段 24 个氨基酸残基的肽(p5),来源于 p35,是 Cdk5 神经元激活物,能特异性抑制 Cdk5-p25 的过度激活和 Tau 的过度磷酸化。
J Biol Chem. 2010 Oct 29;285(44):34202-12. doi: 10.1074/jbc.M110.134643. Epub 2010 Aug 18.
8
Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau.细胞周期蛋白依赖性激酶5激活剂p35的截短会诱导人tau蛋白的Ser202/Thr205发生强烈磷酸化。
J Biol Chem. 2002 Nov 15;277(46):44525-30. doi: 10.1074/jbc.M207426200. Epub 2002 Sep 10.
9
p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.p35/Cdk5通路在体外介导可溶性淀粉样β肽诱导的tau蛋白磷酸化。
J Neurosci Res. 2002 Aug 1;69(3):362-72. doi: 10.1002/jnr.10299.
10
Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.长非编码 RNA 00507/miRNA-181c-5p/TTBK1/MAPT 轴调控阿尔茨海默病中 tau 的过度磷酸化。
J Gene Med. 2020 Dec;22(12):e3268. doi: 10.1002/jgm.3268. Epub 2020 Sep 23.

引用本文的文献

1
A hypothesis explaining Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies overlap.一种解释阿尔茨海默病、帕金森病和路易体痴呆症重叠现象的假说。
Alzheimers Dement. 2025 Jun;21(6):e70363. doi: 10.1002/alz.70363.
2
The Effects of Pb on TNF-R1-RIPK1/RIPK3 Signaling Pathway in the Hippocampus of Mice.铅对小鼠海马 TNF-R1-RIPK1/RIPK3 信号通路的影响。
Neurochem Res. 2024 Nov 27;50(1):36. doi: 10.1007/s11064-024-04279-6.
3
Interplay between microglia and environmental risk factors in Alzheimer's disease.阿尔茨海默病中,小胶质细胞与环境风险因素之间的相互作用。
Neural Regen Res. 2024 Aug 1;19(8):1718-1727. doi: 10.4103/1673-5374.389745. Epub 2023 Dec 11.
4
Environmental Toxins and Alzheimer's Disease: a Comprehensive Analysis of Pathogenic Mechanisms and Therapeutic Modulation.环境毒素与阿尔茨海默病:发病机制与治疗调控的全面分析。
Mol Neurobiol. 2024 Jun;61(6):3657-3677. doi: 10.1007/s12035-023-03805-x. Epub 2023 Nov 25.
5
Common and Trace Metals in Alzheimer's and Parkinson's Diseases.阿尔茨海默病和帕金森病中的常见和痕量金属。
Int J Mol Sci. 2023 Oct 29;24(21):15721. doi: 10.3390/ijms242115721.
6
Metals in Alzheimer's Disease.阿尔茨海默病中的金属
Biomedicines. 2023 Apr 12;11(4):1161. doi: 10.3390/biomedicines11041161.
7
Intermittent Lead Exposure Induces Behavioral and Cardiovascular Alterations Associated with Neuroinflammation.间歇性铅暴露导致与神经炎症相关的行为和心血管改变。
Cells. 2023 Mar 6;12(5):818. doi: 10.3390/cells12050818.
8
Exposure of metal toxicity in Alzheimer's disease: An extensive review.阿尔茨海默病中金属毒性暴露:全面综述。
Front Pharmacol. 2022 Aug 29;13:903099. doi: 10.3389/fphar.2022.903099. eCollection 2022.
9
Developmental Perfluorooctanesulfonic acid (PFOS) exposure as a potential risk factor for late-onset Alzheimer's disease in CD-1 mice and SH-SY5Y cells.发育过程中全氟辛烷磺酸(PFOS)暴露可能是 CD-1 小鼠和 SH-SY5Y 细胞中迟发性阿尔茨海默病的一个潜在风险因素。
Neurotoxicology. 2021 Sep;86:26-36. doi: 10.1016/j.neuro.2021.06.008. Epub 2021 Jul 2.
10
Loss in efficacy measures of tolfenamic acid in a tau knock-out model: Relevance to Alzheimer's disease.tau 敲除模型中托芬酸疗效指标的丧失:与阿尔茨海默病的相关性。
Exp Biol Med (Maywood). 2019 Oct;244(13):1062-1069. doi: 10.1177/1535370219871249. Epub 2019 Aug 26.